Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Augmented Consolidation Therapy Based on Minimal Residual Disease (MRD) and Analysis of the Measurement of Sequential MRD in Childhood Acute Lymphoblastic Leukemia : Children's Cancer and Leukemia Study Group of JAPAN (CCLSG), Cclsg ALL 2004 Protocol Study

Blood (2015) 126 (23): 3724.

https://doi.org/10.1182/blood.V126.23.3724.3724

Published: 2015

Journal Articles

Early Phase Administration of Hematopoietic Stem Cell Transplantation to Prevent Early Relapse for Infants with Acute Lymphoblastic Leukemia and MLL Gene Rearrangement; a Report From the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) Trial MLL03

Katsuyoshi Koh, MD, Daisuke Tomizawa, MD, Akiko Moriya Saito, MD, PhD, Tomoyuki Watanabe, PhD, Atsushi Ogawa, MD, Takashi Sato, MD, Masahiro Hirayama, MD, Yoshihiro Takahashi, MD, Yutaka Saikawa, MD, PhD, Takako Miyamura, MD, Koji Kato, MD, PhD, Kanji Sugita, MD, PhD, Takeyuki Sato, MD, Tomohiko Taki, MD, PhD, Shuki Mizutani, MD, PhD, Masahito Tsurusawa, MD, Keizo Horibe, MD, Eiichi Ishii, MD, PhD

Blood (2010) 116 (21): 529.

https://doi.org/10.1182/blood.V116.21.529.529

Published: 2010

Journal Articles

Augmented Therapy Based on PCR-MRD Levels of Children with Acute Lymphoblastic Leukemia: A Report from the Japanese Children’s Cancer and Leukemia Study Group ALL 2000 MRD Pilot Study

Toshinori Hori, Kazutaka Yamaji, Shohei Yokota, Tomoko Okamoto, Arata Watanabe, Atsushi Kikuta, Keiko Asami, Yasuo Horikoshi, Nobuyuki Hyakuna, Takashi Taga, Keiko Nomura, Asayuki Iwai, Tsutomu Watanabe, Takuya Yanase, Yutaka Saikawa, Akira Kamitamari, Takeji Matsushita, Yasuto Shimomura, Masahito Tsurusawa

Blood (2008) 112 (11): 301.

https://doi.org/10.1182/blood.V112.11.301.301

Published: 2008

Journal Articles

Nation-Wide Survey of Infant Leukemia in Japan: A Report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG).

Takako Miyamura, MD. PhD, Katsuyoshi Koh, MD. PhD, Daisuke Tomizawa, MD, Kanji Sugita, MD. PhD, Koji Kato, MD. PhD, Takashi Sato, MD. PhD, Yoshihiro Takahashi, MD. PhD, Atsushi Ogawa, MD. PhD, Masahiro Hirayama, MD. PhD, Akira Kikuchi, MD. PhD, Megumi Oda, MD. PhD, Daiichiro Hasegawa, MD. PhD, Kazutoshi Koike, MD. PhD, Yutaka Saikawa, MD. PhD, Michiki Hatanaka, MD. PhD, Keizo Horibe, MD. PhD, Eiichi Ishii, MD. PhD

Blood (2008) 112 (11): 896.

https://doi.org/10.1182/blood.V112.11.896.896

Published: 2008

Journal Articles

Different Number of AML1/ETO Transcripts in Single Leukemic Cell, Estimated by Combined Measurement of MRD by FISH and Real-Time PCR, Is a Powerful Predictor of Relapse.

Hideaki Maeba, MD, Ryosei Nishimura, MD, PhD, Rie Kuroda, MD, Toru Horisawa, MD, Yutaka Saikawa, MD, PhD, Shoichi Koizumi, MD, PhD

Blood (2007) 110 (11): 4257.

https://doi.org/10.1182/blood.V110.11.4257.4257

Published: 2007

NARROW

Augmented Consolidation Therapy Based on Minimal Residual Disease (MRD) and Analysis of the Measurement of Sequential MRD in Childhood Acute Lymphoblastic Leukemia : Children's Cancer and Leukemia Study Group of JAPAN (CCLSG), Cclsg ALL 2004 Protocol Study

Early Phase Administration of Hematopoietic Stem Cell Transplantation to Prevent Early Relapse for Infants with Acute Lymphoblastic Leukemia and MLL Gene Rearrangement; a Report From the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) Trial MLL03

Augmented Therapy Based on PCR-MRD Levels of Children with Acute Lymphoblastic Leukemia: A Report from the Japanese Children’s Cancer and Leukemia Study Group ALL 2000 MRD Pilot Study

Nation-Wide Survey of Infant Leukemia in Japan: A Report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG).

Different Number of AML1/ETO Transcripts in Single Leukemic Cell, Estimated by Combined Measurement of MRD by FISH and Real-Time PCR, Is a Powerful Predictor of Relapse.

Email alerts

ASH Publications

American Society of Hematology

Augmented Consolidation Therapy Based on Minimal Residual Disease (MRD) and Analysis of the Measurement of Sequential MRD in Childhood Acute Lymphoblastic Leukemia : Children's Cancer and Leukemia Study Group of JAPAN (CCLSG), Cclsg ALL 2004 Protocol Study

Early Phase Administration of Hematopoietic Stem Cell Transplantation to Prevent Early Relapse for Infants with Acute Lymphoblastic Leukemia and MLL Gene Rearrangement; a Report From the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) Trial MLL03

Augmented Therapy Based on PCR-MRD Levels of Children with Acute Lymphoblastic Leukemia: A Report from the Japanese Children’s Cancer and Leukemia Study Group ALL 2000 MRD Pilot Study

Nation-Wide Survey of Infant Leukemia in Japan: A Report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG).

Different Number of AML1/ETO Transcripts in Single Leukemic Cell, Estimated by Combined Measurement of MRD by FISH and Real-Time PCR, Is a Powerful Predictor of Relapse.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only